Literature DB >> 20842369

A two-mutation model of radiation-induced acute myeloid leukemia using historical mouse data.

Fieke Dekkers1, Harmen Bijwaard, Simon Bouffler, Michele Ellender, René Huiskamp, Christine Kowalczuk, Emmy Meijne, Marjolein Sutmuller.   

Abstract

From studies of the atomic bomb survivors, it is well known that ionizing radiation causes several forms of leukemia. However, since the specific mechanism behind this process remains largely unknown, it is difficult to extrapolate carcinogenic effects at acute high-dose exposures to risk estimates for the chronic low-dose exposures that are important for radiation protection purposes. Recently, it has become clear that the induction of acute myeloid leukemia (AML) in CBA/H mice takes place through two key steps, both involving the Sfpi1 gene. A similar mechanism may play a role in human radiation-induced AML. In the present paper, a two-mutation carcinogenesis model is applied to model AML in several data sets of X-ray- and neutron-exposed CBA/H mice. The models obtained provide good fits to the data. A comparison between the predictions for neutron-induced and X-ray-induced AML yields an RBE for neutrons of approximately 3. The model used is considered to be a first step toward a model for human radiation-induced AML, which could be used to estimate risks of exposure to low doses. © Springer-Verlag 2010

Entities:  

Mesh:

Year:  2010        PMID: 20842369     DOI: 10.1007/s00411-010-0328-7

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  47 in total

1.  Fine-tuning PU.1.

Authors:  Derek L Stirewalt
Journal:  Nat Genet       Date:  2004-06       Impact factor: 38.330

Review 2.  Leukaemia stem cells and the evolution of cancer-stem-cell research.

Authors:  Brian J P Huntly; D Gary Gilliland
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

3.  The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103.

Authors: 
Journal:  Ann ICRP       Date:  2007

4.  AML1-ETO meets JAK2: clinical evidence for the two hit model of leukemogenesis from a myeloproliferative syndrome progressing to acute myeloid leukemia.

Authors:  F Schneider; S K Bohlander; S Schneider; C Papadaki; P Kakadyia; A Dufour; S Vempati; M Unterhalt; M Feuring-Buske; C Buske; J Braess; H Wandt; W Hiddemann; K Spiekermann
Journal:  Leukemia       Date:  2007-07-12       Impact factor: 11.528

5.  Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses.

Authors:  Kai Rothkamm; Markus Löbrich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-04       Impact factor: 11.205

Review 6.  PU.1: a crucial and versatile player in hematopoiesis and leukemia.

Authors:  Philippe Kastner; Susan Chan
Journal:  Int J Biochem Cell Biol       Date:  2007-02-04       Impact factor: 5.085

7.  Myeloid leukaemia and osteosarcoma in CBA/H mice given 224Ra.

Authors:  E R Humphreys; K R Isaacs; T A Raine; J Saunders; V A Stones; D L Wood
Journal:  Int J Radiat Biol       Date:  1993-08       Impact factor: 2.694

Review 8.  Cooperating gene mutations in acute myeloid leukemia: a review of the literature.

Authors:  A Renneville; C Roumier; V Biggio; O Nibourel; N Boissel; P Fenaux; C Preudhomme
Journal:  Leukemia       Date:  2008-02-21       Impact factor: 11.528

9.  Differences in the frequency of normal and clonal precursors of colony-forming cells in chronic myelogenous leukemia and acute myelogenous leukemia.

Authors:  I D Bernstein; J W Singer; F O Smith; R G Andrews; D A Flowers; J Petersens; L Steinmann; V Najfeld; D Savage; S Fruchtman
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

10.  PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain.

Authors:  Wendy D Cook; Benjamin J McCaw; Christopher Herring; Deborah L John; Simon J Foote; Stephen L Nutt; Jerry M Adams
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

View more
  7 in total

Review 1.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

Review 2.  Mouse models for efficacy testing of agents against radiation carcinogenesis—a literature review.

Authors:  Leena Rivina; Robert Schiestl
Journal:  Int J Environ Res Public Health       Date:  2012-12-27       Impact factor: 3.390

Review 3.  PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML.

Authors:  Tom Verbiest; Simon Bouffler; Stephen L Nutt; Christophe Badie
Journal:  Carcinogenesis       Date:  2015-03-06       Impact factor: 4.944

Review 4.  Radiation-induced myeloid leukemia in murine models.

Authors:  Leena Rivina; Michael Davoren; Robert H Schiestl
Journal:  Hum Genomics       Date:  2014-07-25       Impact factor: 4.639

5.  Modeling low-dose radiation-induced acute myeloid leukemia in male CBA/H mice.

Authors:  Sjors Stouten; Sjoerd Verduyn Lunel; Rosemary Finnon; Christophe Badie; Fieke Dekkers
Journal:  Radiat Environ Biophys       Date:  2020-11-22       Impact factor: 1.925

6.  Hyper-radiosensitivity affects low-dose acute myeloid leukemia incidence in a mathematical model.

Authors:  Sjors Stouten; Ben Balkenende; Lars Roobol; Sjoerd Verduyn Lunel; Christophe Badie; Fieke Dekkers
Journal:  Radiat Environ Biophys       Date:  2022-07-21       Impact factor: 2.017

7.  Tracking preleukemic cells in vivo to reveal the sequence of molecular events in radiation leukemogenesis.

Authors:  Tom Verbiest; Rosemary Finnon; Natalie Brown; Lourdes Cruz-Garcia; Paul Finnon; Grainne O'Brien; Eleanor Ross; Simon Bouffler; Cheryl L Scudamore; Christophe Badie
Journal:  Leukemia       Date:  2018-03-03       Impact factor: 11.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.